Home » Topics » BioWorld Science

BioWorld Science
RSS

HUTCHMED begins phase Ib/II study of fruquintinib with tislelizumab in TNBC and endometrial cancer

Aug. 26, 2021

Janssen targets DHODH with new compounds for acute myelogenous leukemia

Aug. 26, 2021

Data presented for Almirall's JAK inhibitor LAS-200019

Aug. 26, 2021

Blade receives IND clearance for phase I study of cudetaxestat for IPF

Aug. 26, 2021

Mutational profiling gives clues to development, new puzzles about disease

Aug. 26, 2021

Memorial Sloan-Kettering Cancer Center describes prodrugs useful in adoptive cell therapy

Aug. 26, 2021

New CREB-2 inhibitors discovered at Evotec International

Aug. 26, 2021

Vertex Pharmaceuticals presents new apolipoprotein L1 inhibitors

Aug. 26, 2021

New Toll-like receptor 7 agonists identified at Bristol Myers Squibb

Aug. 26, 2021

Camino studies SBP-9330 in first-in-human trial for smoking cessation

Aug. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...